Luciferase reporter assay for NF-kB activation automated by an open-source liquid handling platform.


Journal

SLAS technology
ISSN: 2472-6311
Titre abrégé: SLAS Technol
Pays: United States
ID NLM: 101697564

Informations de publication

Date de publication:
Aug 2024
Historique:
received: 05 07 2023
revised: 28 05 2024
accepted: 30 05 2024
medline: 17 9 2024
pubmed: 17 9 2024
entrez: 16 9 2024
Statut: ppublish

Résumé

A luciferase reporter assay is a cell-based, enzymatic experiment that utilizes an ectopically expressed luciferase in cultured cells or in live animals, with the presence of its substrate luciferin, to generate luminescence in response to gene regulation at the level of transcription. This assay can be easily formatted for high-throughput sample analysis. The reagents are commercially available and routinely used in various applications. We have automated a luciferase reporter assay on the Opentrons OT-2 platform to measure activation of NF-kB in HeLa cells. The Python script-based protocols were developed to perform cell seeding, reporter construct transfection, and enzyme-catalytic reaction to produce detectable signals for quantification with desirable quality of sample handling and minimal hands-on time.

Identifiants

pubmed: 39284642
pii: S2472-6303(24)00037-2
doi: 10.1016/j.slast.2024.100155
pii:
doi:

Substances chimiques

Luciferases EC 1.13.12.-
NF-kappa B 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100155

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interests The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Boren Lin and Kinnari Watson are currently employees of Opentrons Labworks Inc

Auteurs

Boren Lin (B)

Opentrons Labworks Inc., New York, NY 11101, USA. Electronic address: boren.lin@opentrons.com.

Kinnari Watson (K)

Opentrons Labworks Inc., New York, NY 11101, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH